L’utilisation des anticoagulants oraux directs chez les patients âgés : les limites de la médecine fondée sur les preuves ?

Jørgensen, 2008, Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions, BMC Med Res Methodol, 8, 60, 10.1186/1471-2288-8-60 Lundh, 2012, Industry sponsorship and research outcome, Cochrane Database Syst Rev, 12, MR000033 Khan, 2012, Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis, Arthritis Rheum, 64, 2059, 10.1002/art.34393 Ruff, 2014, Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials, Lancet, 383, 955, 10.1016/S0140-6736(13)62343-0 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Giugliano, 2013, Edoxaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 369, 2093, 10.1056/NEJMoa1310907 Cosgrove, 2013, Conflicts of interest and the quality of recommendations in clinical guidelines, J Eval Clin Pract, 19, 674, 10.1111/jep.12016 Neuman, 2011, Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study, BMJ, 343, d5621, 10.1136/bmj.d5621 Bindslev, 2013, Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study, BMC Med Ethics, 14, 19, 10.1186/1472-6939-14-19 Graham, 2015, Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation, Circulation, 131, 157, 10.1161/CIRCULATIONAHA.114.012061 Prins, 2013, Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies, Thromb J, 11, 21, 10.1186/1477-9560-11-21 Sardar, 2014, New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials, J Am Geriatr Soc, 62, 857, 10.1111/jgs.12799 Chan, 2014, Increasing value and reducing waste: addressing inaccessible research, Lancet, 383, 257, 10.1016/S0140-6736(13)62296-5 Reach, 2014, Clinical inertia, uncertainty and individualized guidelines, Diabetes Metab, 40, 241, 10.1016/j.diabet.2013.12.009 Osler, 1961